[Analysis on trends of mortality rate and disease burden of liver cancer in Tianjin, China from 1999 to 2021].

Q3 Medicine
D Z Wang, S Zhang, H Zhang, C F Shen, C Wang, L N Xun, W L Zheng, G H Jiang
{"title":"[Analysis on trends of mortality rate and disease burden of liver cancer in Tianjin, China from 1999 to 2021].","authors":"D Z Wang, S Zhang, H Zhang, C F Shen, C Wang, L N Xun, W L Zheng, G H Jiang","doi":"10.3760/cma.j.cn112152-20240101-00001","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To explore the trends and distribution of liver cancer between sexes, ages, and urban-rural areas in Tianjin, China from 1999 to 2021, and provide data for targeted prevention and control strategies of liver cancer in Tianjin. <b>Methods:</b> Liver cancer mortality data of Tianjin during 1999-2021 were from the Tianjin population based mortality surveillance system maintained by the Tianjin Centers for Disease Control and Prevention (CDC), and the population data of permanent Tianjin residents were from Tianjin Municipal Public Security Bureau. Liver cancer mortality, years of life lost (YLL), years lived with disability (YLD), and disability adjusted life years (DALY) were calculated using the cause of death surveillance data collected by Tianjin Centers for Disease Control and Prevention. The distributions of these data among residents of different sexes, ages, and regions were analyzed. Segi's world standard population was used for standardization. Joinpoint regression was used for trend analysis on the mortality rate of liver cancer and the disease burden. <b>Results:</b> The liver cancer mortality rate in Tianjin decreased by 46.75% from 1999 to 2021, with distinct phased characteristics. From 1999 to 2010, the age-sex-standardized mortality rate (SMR) decreased from 12.62/100 000 to 11.64/100 000 with an annual percent change (APC) of -1.32% (<i>P</i>=0.003). From 2010 to 2021, the SMR decreased from 11.64/100 000 to 6.72/100 000 (APC=-3.89%, <i>P</i><0.001). The age-sex-standardized DALY rates(SDR) decreased by 50.63% from 1999 to 2021, also with distinct phased characteristics. From 1999 to 2010, the SDR decreased from 388.67/100 000 to 349.38/100 000 (APC=-1.35%, <i>P</i>=0.002). From 2010 to 2021, the SDR decreased from 349.38/100 000 to 191.88/100 000 (APC=-4.43%, <i>P</i><0.001). The liver cancer mortality rate declined most rapidly in the age group under 45 years; the APC for those under 35 years was -5.07% (<i>P</i><0.001), and for those aged 35-44 years, the APC was 0.63% (<i>P</i>=0.707) and -8.21% (<i>P</i><0.001) before and after 2007, respectively. Both SMR and SDR were significantly higher in males than in females (<i>P</i><0.01). Both SMR and SDR were significantly higher in urban areas than in rural areas from 1999 to 2007 (<i>P</i><0.05), but they became similar after 2008. Liver cancer DALY are predominantly YLL, accounting for 99%. The median age of liver cancer deaths in Tianjin during 1999-2021 was 64-68 years old, with males lower than females (<i>P</i><0.05), and rural areas lower than urban areas (<i>P</i><0.05), generally showing an increasing trend (1999-2014: APC=0.11%, <i>P</i>=0.047; 2014-2021: APC=0.51%, <i>P</i>=0.005). <b>Conclusions:</b> Liver cancer mortality rate and disease burden decreased from 1999 to 2021 in Tianjin, with an especially accelerated decline after 2010. Further efforts to reduce liver cancer mortality in Tianjin are needed, and special attention should be focused on the elderly, male, and rural residents.</p>","PeriodicalId":39868,"journal":{"name":"中华肿瘤杂志","volume":"46 11","pages":"999-1008"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华肿瘤杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112152-20240101-00001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the trends and distribution of liver cancer between sexes, ages, and urban-rural areas in Tianjin, China from 1999 to 2021, and provide data for targeted prevention and control strategies of liver cancer in Tianjin. Methods: Liver cancer mortality data of Tianjin during 1999-2021 were from the Tianjin population based mortality surveillance system maintained by the Tianjin Centers for Disease Control and Prevention (CDC), and the population data of permanent Tianjin residents were from Tianjin Municipal Public Security Bureau. Liver cancer mortality, years of life lost (YLL), years lived with disability (YLD), and disability adjusted life years (DALY) were calculated using the cause of death surveillance data collected by Tianjin Centers for Disease Control and Prevention. The distributions of these data among residents of different sexes, ages, and regions were analyzed. Segi's world standard population was used for standardization. Joinpoint regression was used for trend analysis on the mortality rate of liver cancer and the disease burden. Results: The liver cancer mortality rate in Tianjin decreased by 46.75% from 1999 to 2021, with distinct phased characteristics. From 1999 to 2010, the age-sex-standardized mortality rate (SMR) decreased from 12.62/100 000 to 11.64/100 000 with an annual percent change (APC) of -1.32% (P=0.003). From 2010 to 2021, the SMR decreased from 11.64/100 000 to 6.72/100 000 (APC=-3.89%, P<0.001). The age-sex-standardized DALY rates(SDR) decreased by 50.63% from 1999 to 2021, also with distinct phased characteristics. From 1999 to 2010, the SDR decreased from 388.67/100 000 to 349.38/100 000 (APC=-1.35%, P=0.002). From 2010 to 2021, the SDR decreased from 349.38/100 000 to 191.88/100 000 (APC=-4.43%, P<0.001). The liver cancer mortality rate declined most rapidly in the age group under 45 years; the APC for those under 35 years was -5.07% (P<0.001), and for those aged 35-44 years, the APC was 0.63% (P=0.707) and -8.21% (P<0.001) before and after 2007, respectively. Both SMR and SDR were significantly higher in males than in females (P<0.01). Both SMR and SDR were significantly higher in urban areas than in rural areas from 1999 to 2007 (P<0.05), but they became similar after 2008. Liver cancer DALY are predominantly YLL, accounting for 99%. The median age of liver cancer deaths in Tianjin during 1999-2021 was 64-68 years old, with males lower than females (P<0.05), and rural areas lower than urban areas (P<0.05), generally showing an increasing trend (1999-2014: APC=0.11%, P=0.047; 2014-2021: APC=0.51%, P=0.005). Conclusions: Liver cancer mortality rate and disease burden decreased from 1999 to 2021 in Tianjin, with an especially accelerated decline after 2010. Further efforts to reduce liver cancer mortality in Tianjin are needed, and special attention should be focused on the elderly, male, and rural residents.

天津市1999 - 2021年肝癌死亡率及疾病负担趋势分析
目的:探讨天津市1999 - 2021年肝癌在性别、年龄和城乡之间的变化趋势和分布,为天津市肝癌的针对性防治策略提供数据。方法:天津市1999-2021年肝癌死亡率数据来源于天津市疾病预防控制中心人口死亡率监测系统,天津市常住人口数据来源于天津市公安局。肝癌死亡率、丧失生命年(YLL)、残疾生存年(YLD)和残疾调整生命年(DALY)采用天津市疾病预防控制中心收集的死亡原因监测数据进行计算。分析了这些数据在不同性别、年龄和地区居民中的分布。Segi的世界标准人口被用于标准化。采用联合点回归对肝癌死亡率与疾病负担进行趋势分析。结果:天津市肝癌死亡率从1999年到2021年下降46.75%,具有明显的阶段性特征。从1999年到2010年,年龄-性别标准化死亡率(SMR)从12.62/10万下降到11.64/10万,年变化率(APC)为-1.32% (P=0.003)。从2010年到2021年,SMR从11.64/10万下降到6.72/10万(APC=-3.89%, P<0.001)。1999 - 2021年,年龄-性别标准化DALY率(SDR)下降50.63%,也具有明显的阶段性特征。1999 - 2010年SDR由388.67/10万下降至349.38/10万(APC=-1.35%, P=0.002)。2010年至2021年,SDR由349.38/10万下降至191.88/10万(APC=-4.43%, P<0.001)。肝癌死亡率在45岁以下年龄组下降最快;2007年前后35岁以下人群APC为-5.07% (P<0.001), 35 ~ 44岁人群APC分别为0.63% (P=0.707)和-8.21% (P<0.001)。男性患者SMR和SDR均显著高于女性(P<0.01)。1999 - 2007年,城市地区的SMR和SDR均显著高于农村地区(P<0.05),但2008年以后两者趋于一致。肝癌DALY以YLL为主,占99%。天津市1999-2021年肝癌死亡中位年龄为64-68岁,男性低于女性(P<0.05),农村低于城市(P<0.05),总体呈上升趋势(1999-2014年:APC=0.11%, P=0.047;2014-2021年:apc =0.51%, p =0.005)。结论:天津市肝癌死亡率和疾病负担在1999 - 2021年间呈下降趋势,2010年后下降速度加快。天津市需要进一步努力降低肝癌死亡率,并应特别关注老年人、男性和农村居民。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华肿瘤杂志
中华肿瘤杂志 Medicine-Medicine (all)
CiteScore
1.40
自引率
0.00%
发文量
10433
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信